This study presents a comprehensive biochemical profile of 92 clinical kinase inhibitors—86 of which are FDA-approved—tested against a panel of 758 kinases. By examining 409 wild-type and 349 oncogenic variants, the researchers expanded the known landscape of druggable kinases from 89 to 235. The results reveal significant polypharmacology, demonstrating that most approved drugs inhibit additional...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动
前往小宇宙评论区与主播互动
Fler avsnitt av Paper Talk
Visa alla avsnitt av Paper TalkPaper Talk med 淼淼Elva finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
